Jeffery D. Molkentin

Jeffery Daniel Molkentin (born January 15, 1967 in Milwaukee, Wisconsin) is an American molecular biologist. He is the director of Molecular Cardiovascular Biology for Cincinnati Children's hospital where he is also co-director of their Heart Institute. Molkentin holds a professorship at the University of Cincinnati's Department of Pediatrics.
Biography.
Molkentin was born and raised in Milwaukee, Wisconsin., where he attended Marquette University, receiving a B.S. in biology in 1989. He began studies to be a medical doctor at the University of Wisconsin, but switched to a research program, and received his PhD in physiology from the Medical College of Wisconsin in 1994.
Molkentin's work focuses on heart disease and muscular dystrophy, though he is involved in other types of research entailing calcium handling, ER stress signaling, cardiac hypertrophic signaling pathways, and COVID-19 disease mechanisms. One of Molkentin's most notable research achievements was his contribution to stem cell therapy in the heart and his disproving prior research about the topic.
Molkentin is among the most highly cited researchers in the world, with his publications being cited over 50,000 times in literature. His work has been published in several prestigious research journals, including "Nature", "PNAS", and "Circulation Research".
Molkentin has been a full investigator for the Howard Hughes Medical Institute (HHMI) since 2008.